Purchase Order W911QY20P0036
Award Date
2/15/20
Potential Completion Date
9/30/20
Potential Value
$167K
Funding Federal Agency
Joint PEO Chemical and Biological Defense
Contracting Federal Agency
ACC Aberdeen Proving Ground
Awardee
Consegna Pharma Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Set-Aside Type
Total Small Business
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Carson, PA 15203, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,099,999.92 Firm Fixed Price SBIR Phase II contract awarded by the Joint PEO Chemical and Biological Defense, a component of the U.S. Army, to Consegna Pharma Inc., a small disadvantaged business. The contract is for the development of a long-duration opioid overdose antagonist. This award follows a prior $167,421 SBIR Phase I contract Consegna received from the Army for additional pharmaceutical research and development. Consegna has also received several grants from the National...
This federal contract award, valued at $12,577.38, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and critical care materials such as syringes and vials. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent...
This federal contract award, valued at $1,489.93, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and various medical devices and supplies. The award is a child contract under a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award is for a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, from the Defense Logistics Agency (DLA). The $12,557.40 firm fixed-price contract is for the provision of pharmaceutical products and medical supplies, including specialty medications, generic drugs, brand-name pharmaceuticals, medical devices, syringes, vials, and other critical healthcare commodities. The contract is part of a larger Indefinite Delivery Contract (IDC)...
This is a $1,466,682.62 Firm Fixed Price contract awarded by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to CMC Pharmaceuticals, Inc. (CMC), a woman-owned small business, under the Small Business Innovation Research (SBIR) Program Phase II. The contract is for drug formulation development and complex drug delivery system services related to pharmaceutical products such as atropine sulfate formulations and scopolamine hydrobromide vials. CMC has...
This federal contract award, valued at $12,025.90, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for a pharmaceutical prime vendor delivery order, providing a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract encompasses critical...
The federal contract award, valued at $78,986.18, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range...
The federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of pharmaceutical products and medical supplies. The award, valued at $1,672.41, is a delivery order contract with a firm-fixed-price pricing type. The contract does not have a set-aside designation. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support...
This federal contract award is a $18,321.44 Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not designated with a set-aside requirement, indicating open competition. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle...
The federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,748.35, is for the provision of pharmaceutical products and medical supplies to support military and veterans' healthcare programs. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...